Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nadiminti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Heart Journal|May 1, 1983
Bundle branch block in acute myocardial infarctionG Hollander, V Nadiminti, E Lichstein, et al.
Transplantation and Cellular Therapy|August 3, 2025
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR AnalysisKalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Blood Advances|November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 StudyAndrew S Artz, Brent R Logan, Wael Saber, et al.
Transplantation and Cellular Therapy|June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell LymphomaNausheen Ahmed, Alaa Ali, Soyoung Kim, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Heart Journal|May 1, 1983
Bundle branch block in acute myocardial infarctionG Hollander, V Nadiminti, E Lichstein, et al.
Transplantation and Cellular Therapy|August 3, 2025
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR AnalysisKalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Blood Advances|November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 StudyAndrew S Artz, Brent R Logan, Wael Saber, et al.
Transplantation and Cellular Therapy|June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell LymphomaNausheen Ahmed, Alaa Ali, Soyoung Kim, et al.
Pageof 1